Stanford and Intonation partner to develop new treatments for neuroendocrine tumors

FHS
June 24, 2023
2:33 am

Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.

The term ‘vegetative state’ has no place in modern medicine

A stroke, a traumatic brain injury — at any moment, any one of us could leave behind our normal state of consciousness and start to

November 20, 2024

Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment

Federal officials on Friday said health providers could prescribe drugs for opioid addiction and ADHD over telehealth for one more year, ending a months-long stalemate

November 15, 2024

Internal documents shed new light on Sarepta FDA decision, which top agency official says was ‘exceptional’

While he has repeatedly advocated for accelerated gene therapy approvals, the FDA’s top cell and gene therapy official Peter Marks said that the agency’s landmark

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.